Federated Hermes
PRAX icon

Federated Hermes’s Praxis Precision Medicines PRAX Stock Holding History

Federated Hermes’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7K Hold
44
– – ﹤0.01% 1807
2026
Q1 		$14.2K Hold
44
– – ﹤0.01% 1820
2025
Q4 		$13K Buy
+44
New +$8.19K ﹤0.01% 1815
2023
Q3 		– Sell
-24,379
Closed -$421K – 2179
2023
Q2 		$421K Sell
24,379
-1,472
-6% -$22.5K ﹤0.01% 1424
2023
Q1 		$314K Buy
25,851
+1,289
+5% +$54.4K ﹤0.01% 1516
2022
Q4 		$877K Buy
24,562
+18,997
+341% +$592K ﹤0.01% 1175
2022
Q3 		$189K Buy
+5,565
New +$277K ﹤0.01% 1525

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Federated Hermes's PRAX Position: Q2 2026 in Review

Federated Hermes held its Praxis Precision Medicines (PRAX) position steady in Q2 2026 at 44 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1807.

Federated Hermes first reported a position in PRAX in Q3 2022 and has held it in 7 quarters since. The position peaked at $877K in Q4 2022. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Federated Hermes held 44 shares of Praxis Precision Medicines worth $14.7K as of Q2 2026.
  • Federated Hermes left its Praxis Precision Medicines share count unchanged in Q2 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1807 holding.
  • Federated Hermes first reported a position in Praxis Precision Medicines in Q3 2022 and has held it in 7 quarters since.
  • Federated Hermes's Praxis Precision Medicines position peaked at $877K in Q4 2022.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.